VAERS reports by lot

GSK DTaP/Tdap lot 594SR: VAERS reports

23 VAERS reports list lot 594SR as a GSK DTaP/Tdap vaccine, received between 2017-05-24 and 2021-04-13. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
13%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2533%
Neurological1317%
General / Systemic (non-local)1114%
Musculoskeletal811%
Allergic / Anaphylactic68%
Cardiac / Cardiovascular45%
Gastrointestinal45%
Dermatological (non-injection-site)34%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Kentucky2
Florida2
Virginia2
Michigan1
Minnesota1
Puerto Rico1
North Carolina1
Oregon1
Ohio1
Texas1
Connecticut1

Reports by month received

2017-051
2017-064
2017-079
2017-083
2017-091
2017-102
2018-011
2020-071
2021-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.